All Stories

Guest Post: Robert Sutherland Smith - is AstraZeneca a buy after Q1 numbers?

Tom Winnifrith
Thursday 2 May 2013

Robert Sutherland Smith is again proving that he is still alive with another guest post. Robert started his City career the year before I was born and is, I think, 157 years old. Fear not. He is very much alive and kicking. He and I have worked together for almost eight years at t1ps.com . He is my friend and he is a very funny and intelligent chap. He is now branching out to celebrate his 158th by doing some freelance writing over  at various places ( including Shareprophets.com naturally) on FTSE 350 Income stocks. Robert is a speaker at the UKInvestor Show on April 5th 2014. He is a great one for focussing on yield. RSS today looks at AstraZeneca. RSS writes:

With the first quarter’s results from Astra Zeneca (AZN) the curtain has gone up for the first act of what we all know will be a tough and difficult year; a stock market version of Gounod’s Faust but with a happier ending we trust. At least that is what the market expects to judge from the fact that the share price has risen some ten per cent from since the introduction and appointment of the new Chief Executive (whose name almost rhymes with Poirot) and his plan plus the fact the share price did not fall significantly on their publication - ending down 4.5p on the day to 3321p a share.  His plan is to transform the company from its co-operative, external economy dividend favouring model, back to the drug discovery orthodoxy of more internally funded research and development; leaving the question hanging in the air about whether the company can  increase internal R&D spending while at the same time maintain and increase dividends?

on TradingResearchPoint | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read